Rare constitutional anemia

Rare constitutional anemia is a broad grouping term used in the Orphanet classification (ORPHA:183651) to encompass a heterogeneous collection of rare inherited (constitutional) anemias. These are genetic disorders in which the body fails to produce an adequate number of functional red blood cells, leading to reduced oxygen delivery to tissues. Constitutional anemias are present from birth or early life and arise from intrinsic defects in red blood cell production, structure, metabolism, or hemoglobin synthesis, distinguishing them from acquired forms of anemia. This category includes a wide spectrum of conditions such as hereditary spherocytosis, sickle cell disease, thalassemias, Diamond-Blackfan anemia, Fanconi anemia, congenital dyserythropoietic anemias, red cell enzyme deficiencies (e.g., pyruvate kinase deficiency, glucose-6-phosphate dehydrogenase deficiency), and other rare inherited bone marrow failure syndromes. The primary body system affected is the hematologic (blood) system, though secondary effects on the spleen, liver, heart, bones, and other organs are common depending on the specific underlying condition. Key symptoms shared across many of these disorders include pallor, fatigue, weakness, jaundice, and in some cases splenomegaly or growth delay. Because this is a classification grouping rather than a single disease entity, the treatment landscape varies widely depending on the specific diagnosis. Treatments may range from supportive care such as red blood cell transfusions and iron chelation therapy, to pharmacologic agents (e.g., hydroxyurea for sickle cell disease), to potentially curative approaches including hematopoietic stem cell transplantation and emerging gene therapies. Genetic counseling is recommended for affected families, and early diagnosis through newborn screening or genetic testing can significantly improve outcomes.

Common questions about Rare constitutional anemia